Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101852-2 Fluorometholone SCnc Urine Pt Qn     ACTIVE Fluorometholone [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101852-2         Both       0 Fluorometholone Ur-sCnc       N   DRUG/TOXICOLOGY; Drugs; FML Forte Liquifilm; FML Liquifilm; FML S.O.P.; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101853-0 Fluticasone propionate SCnc Urine Pt Qn     ACTIVE Fluticasone propionate [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101853-0         Both       0 Fluticasone Prop Ur-sCnc       N   Cutivate; DRUG/TOXICOLOGY; Drugs; Flonase; Flovent; Level; Point in time; Propanoic acid; Propioate; Propioic acid; Propionic acid; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101854-8 Megestrol acetate SCnc Urine Pt Qn     ACTIVE Megestrol acetate [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101854-8         Both       0 Megestrol Acetate Ur-sCnc       N   Acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; Level; Megace; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101855-5 Methylprednisolone SCnc Urine Pt Qn     ACTIVE Methylprednisolone [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101855-5         Both       0 Me-prednisolone Ur-sCnc       N   DRUG/TOXICOLOGY; Drugs; Level; MeP; Me-prednisolone; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101856-3 prednisoLONE SCnc Urine Pt Qn     ACTIVE prednisoLONE [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101856-3         Both       0 prednisoLONE Ur-sCnc       N   c424; Deltasone; Depo-Medrol; DRUG/TOXICOLOGY; Drugs; Kenalog; Level; Medrol; Point in time; QNT; Quan; Quant; Quantitative; Random; Solu-Medrol; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101857-1 predniSONE SCnc Urine Pt Qn     ACTIVE predniSONE [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101857-1         Both       0 predniSONE Ur-sCnc       N   C254; Cortan; Deltasone; DRUG/TOXICOLOGY; Drugs; Level; Liquid Pred; Meticorten; Orasone; Panasol-S; Point in time; Prednicen-M; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101858-9 Triamcinolone acetonide SCnc Urine Pt Qn     ACTIVE Triamcinolone acetonide [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101858-9         Both       0 Triamcinolone Aceto Ur-sCnc       N   Aristocort; Atolone; Azmacort; DRUG/TOXICOLOGY; Drugs; Kenacort; Kenalog; Level; Mycolog II; Nasacort; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
101859-7 Triamcinolone SCnc Urine Pt Qn     ACTIVE Triamcinolone [Moles/volume] in Urine   MAJ DefinitionDescription     nmol/L             DRUG/TOX   101859-7         Both       0 Triamcinolone Ur-sCnc       N   Aristocort; Atolone; DRUG/TOXICOLOGY; Drugs; Kenacort; Kenalog; Level; Mycolog II; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.76 2.75               nmol/L       0
10186-5 Identifying information Find ^Patient Pt Nar Observed   ACTIVE Identifying information Narrative Observed   MIN DefinitionDescription                   H&P.HX   10186-5   Observed             0 Identifying information Observ           Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report 2.4 1.0i                       0
101860-5 4F-MDMB-BUTICA MCnc Urine Pt Qn Confirm   ACTIVE 4F-MDMB-BUTICA [Mass/volume] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mL             DRUG/TOX   101860-5   Confirm     Observation       0 4F-MDMB-BUTICA Ur Cfm-mCnc       N   4F-Mdmb-bica; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; L-Valine, N-((1-(4-fluorobutyl)-1H-indol-3-yl)carbonyl)-3-methyl-, methyl ester; Mass concentration; Methyl N-{[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.75 2.75               ng/mL       0
101861-3 4F-MDMB-BUTICA/Creatinine MRto Urine Pt Qn Confirm   ACTIVE 4F-MDMB-BUTICA/Creatinine [Mass Ratio] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mg             DRUG/TOX   101861-3   Confirm     Observation       0 4F-MDMB-BUTICA/Creat Ur Cfm       N   4F-Mdmb-bica; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; L-Valine, N-((1-(4-fluorobutyl)-1H-indol-3-yl)carbonyl)-3-methyl-, methyl ester; Mass concentration ratio; Mass ratio; MCRto; Methyl N-{[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn 2.75 2.75               ng/mg       0
101862-1 4F-MDMB-BUTICA PrThr Urine Pt Ord Confirm   ACTIVE 4F-MDMB-BUTICA [Presence] in Urine by Confirmatory method   ADD DefinitionDescription                   DRUG/TOX   101862-1   Confirm     Observation       0 4F-MDMB-BUTICA Ur Ql Cfm       N   4F-Mdmb-bica; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; L-Valine, N-((1-(4-fluorobutyl)-1H-indol-3-yl)carbonyl)-3-methyl-, methyl ester; Methyl N-{[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.75 2.75                       0
101863-9 Complement factor H Ab ACnc Ser/Plas Pt Qn IA   ACTIVE Complement factor H Ab [Units/volume] in Serum or Plasma by Immunoassay   ADD DefinitionDescription     IU/mL             HEM/BC   101863-9   IA     Both       0 Comp Fact H Ab SerPl IA-aCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Beta 1 H; Bombay AB; C3b inactivator accelerator; Comp; Comp Fact H; Complmt; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; HEMATOLOGY/CELL COUNTS; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS 2.75 2.75               [IU]/mL       0
101864-7 Oxygen/Gas.total setting VFr ECMO device Pt Qn     ACTIVE Oxygen/Total gas setting ECMO device   ADD DefinitionDescription     %             PULM   101864-7         Both       0 O2/Total gas setting VFr ECMO device       N   Gases; O2; O2/gas .tot set; Percent; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Total gas setting; Totl; Volfr; Volume fraction 2.75 2.75               %       0
101865-4 Troponin T. cardiac 2H &6H 5th generation panel - Ser/Plas - - High sensitivity   ACTIVE Troponin T. cardiac 2H and 6H 5th generation panel in Serum or Plasma by High sensitivity method   ADD DefinitionDescription                   PANEL.CHEM   101865-4   High sensitivity     Order       0 Troponin T 2H 6H 5th gen SerPl HS       N   120 min; 120 minutes; 120min; 2 hours; Chemistry; cTnT; HS; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin; Troponin T 2H 6H 2.75 2.75   Panel                   0
101866-2 Gas and electrolytes point of care panel - BldV Pt -     ACTIVE Gas and electrolytes point of care panel - Venous blood   MAJ DefinitionDescription                   PANEL.CHEM   101866-2         Order       0 Gas + Electrolytes poc pnl BldV       N   Bld ven; Bld venous; Blood - venous; Blood gas ven; Blood ven; Blood venus; Chemistry; Elect; Electr; Electrolyte; Gas + Electrolytes poc pnl; Gases; Lytes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Venous 2.76 2.75   Panel                   0
101867-0 Ma2 Antibody PrThr CSF Pt Ord IA   ACTIVE Ma2 Antibody [Presence] in Cerebral spinal fluid by Immunoassay   MAJ DefinitionDescription                   SERO   101867-0   IA     Both       0 Ma2 Ab CSF Ql IA       N   Ab; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Ma2 Ab; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS 2.76 2.75                       0
101868-8 Ma2 Antibody PrThr Ser/Plas Pt Ord IA   ACTIVE Ma2 Antibody [Presence] in Serum or Plasma by Immunoassay   MAJ DefinitionDescription                   SERO   101868-8   IA     Both       0 Ma2 Ab SerPl Ql IA       N   Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Ma2 Ab; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS 2.76 2.75                       0
10187-3 Review of systems Find ^Patient Pt Nar Reported   ACTIVE Review of systems Narrative - Reported   MIN DefinitionDescription                   H&P.HX   10187-3   Reported             0 Review of systems           Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report 2.63 1.0i                       0
101870-4 Gamma aminobutyrate A receptor Ab.IgG Titr CSF Pt SemiQn CBA IFA   ACTIVE GABAAR IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay   MAJ DefinitionDescription     titer             SERO   101870-4   CBA IFA     Both       0 GABAAR IgG Titr CSF CBA IFA       N   4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); GABA; GABAAR; GABAAR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr 2.76 2.75               {titer}       0
101871-2 IgLON family member 5 Ab.IgG Titr CSF Pt SemiQn CBA IFA   ACTIVE IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay   MAJ DefinitionDescription     titer             SERO   101871-2   CBA IFA     Both       0 IgLON5 IgG Titr CSF CBA IFA       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); IgLON5; IgLON5 Ab; IgLON5 IgG; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr 2.76 2.75               {titer}       0
101872-0 Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG Titr CSF Pt SemiQn CBA IFA   ACTIVE Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay   MAJ DefinitionDescription     titer             SERO   101872-0   CBA IFA     Both       0 IP3R 1 IgG Titr CSF CBA IFA       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cyclohexane-1,2,3,4,5,6-hexol; Dilution factor; Dilution Factor (Titer); i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; InsP3R1; IP3 receptor isoform 1; IP3R 1; IP3R 1 Ab; IP3R 1 IgG; ITPR; ITPR1; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr; Type 1 inositol 1,4,5-trisphosphate receptor; Type 1 InsP3 receptor 2.76 2.75               {titer}       0
101873-8 Metabotropic glutamate receptor 1 Ab.IgG Titr CSF Pt SemiQn CBA IFA   ACTIVE Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay   MAJ DefinitionDescription     titer             SERO   101873-8   CBA IFA     Both       0 mGluR1 IgG Titr CSF CBA IFA       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Glu; Glutamic acid; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; mGluR1; mGluR1 Ab; mGluR1 IgG; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr 2.76 2.75               {titer}       0
101874-6 Gamma aminobutyrate A receptor Ab.IgG PrThr Ser Pt Ord CBA IFA   ACTIVE GABAAR IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay   ADD DefinitionDescription                   SERO   101874-6   CBA IFA     Both       0 GABAAR IgG Ser Ql CBA IFA       N   4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GABA; GABAAR; GABAAR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR 2.75 2.75                       0
101875-3 Gamma aminobutyrate A receptor Ab.IgG Titr Ser Pt SemiQn CBA IFA   ACTIVE GABAAR IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay   MAJ DefinitionDescription     titer             SERO   101875-3   CBA IFA     Both       0 GABAAR IgG Titr Ser CBA IFA       N   4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); GABA; GABAAR; GABAAR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.76 2.75               {titer}       0
104,672 results found